✦ LIBER ✦

Is breast cancer a progressive or systemic disease?

✍ Scribed by J.P. van Netten; A.S. Ross; S.A. Cann; D.M. Derry; M.J. Ashwood Smith

Book ID: 118557352
Publisher: The Lancet
Year: 1995
Tongue: English
Weight: 328 KB
Volume: 345
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(95)90308-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Flap recurrence following mastectomy for

Flap recurrence following mastectomy for breast cancer: local failure or systemic disease

✍ G.J. Byrne; C.S. Bronder; R. Swindell; A. Howell; N.J. Bundred 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Is primary sclerosing cholangitis a prog

Is primary sclerosing cholangitis a progressive disease or not?

✍ Russell H. Wiesner; Patricia Grambsch; Nicholas F. Larusso; E. Rolland Dickson 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB 👁 1 views

Osteoarthritis: Is OA a mechanical or sy

Osteoarthritis: Is OA a mechanical or systemic disease?

✍ Cicuttini, Flavia M.; Wluka, Anita E. 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 913 KB

Breast cancer as a systemic disease: a v

Breast cancer as a systemic disease: a view of metastasis

✍ Redig, A. J.; McAllister, S. S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 669 KB

AberrantBLIDexpression is associated wit

AberrantBLIDexpression is associated with breast cancer progression

✍ Li, Xiaoyan; Su, Peng; Liu, Xianqiang; Kong, Xiangnan; Zhang, Xin; Zhang, Hongyu 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 237 KB

Hyperprolactinemia is an indicator of pr

Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer

✍ Wilhelm Holtkamp; Gerd Arno Nagel; Hans-Erik Wander; Helmut Franz Rauschecker; D 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 French ⚖ 573 KB

## Abstract In a long‐term follow‐up study, prolactin levels were measured in 149 patients with advanced metastatic breast cancer. Control groups included 221 patients with primary operable breast cancer and 150 women with benign breast disease. Hyperprolactinemia (>1,000 mlU/l; HYPRL) occurs in 44